Obsidian Therapeutics

Obsidian Therapeutics is a clinical-stage biotechnology company developing engineered cell and gene therapies built on its proprietary cytoDRiVE platform, which uses drug-responsive domains to regulate therapeutic protein function with an FDA-approved small molecule. Its lead program, OBX-115, is in Phase 2 trials for advanced melanoma. The company was surfaced as a portfolio company of GV and added to the API Evangelist network. It is a life-sciences company with no public developer or API surface.

Obsidian Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Cell and Gene Therapy, and Pharmaceuticals.

Obsidian Therapeutics’ developer surface includes engineering blog, support, and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub
13.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyLife SciencesBiotechnologyCell and Gene TherapyPharmaceuticalsPrecision MedicineOncology

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 13.0/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/obsidian-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Operate 1

Status, limits, changes, and where to get help

Support
Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: obsidian-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/obsidian-therapeutics.png
name: Obsidian Therapeutics
description: Obsidian Therapeutics is a clinical-stage biotechnology company developing engineered cell and gene therapies
  built on its proprietary cytoDRiVE platform, which uses drug-responsive domains to regulate therapeutic protein function
  with an FDA-approved small molecule. Its lead program, OBX-115, is in Phase 2 trials for advanced melanoma. The company
  was surfaced as a portfolio company of GV and added to the API Evangelist network. It is a life-sciences company with no
  public developer or API surface.
url: https://raw.githubusercontent.com/api-evangelist/obsidian-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Life Sciences
- Biotechnology
- Cell and Gene Therapy
- Pharmaceuticals
- Precision Medicine
- Oncology
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://obsidiantx.com
- type: Blog
  url: https://obsidiantx.com/news/
- type: Support
  url: https://obsidiantx.com/contact/
- type: PrivacyPolicy
  url: https://obsidiantx.com/privacy-policy
- type: TermsOfService
  url: https://obsidiantx.com/terms-of-use/
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1